Registered entities
ELOXX PHARMACEUTICALS, INC.
Reg. No. 1035354United States
Innovation
10 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 972 times.
| Year | Filings |
|---|---|
| 2015 | 1 |
| 2017 | 5 |
| 2018 | 6 |
| 2019 | 8 |
| 2020 | 5 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 1 |
Investor mix
17 investors on record; lead investors include Genome Quebec, Genome Canada, Pontifax, Life Sciences Partners; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 29% |
| Private equity | 5 | 29% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 6 | 35% |